Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This early-stage study tested the safety and how the body processes a new injectable drug called HDM1005 in people who are overweight or obese. Forty participants received either the drug or a placebo (inactive shot) at different dose levels to see how well it was tolerated. The …

This study tested a cream called roflumilast for people with mild to moderate eczema (atopic dermatitis). 354 participants applied the cream or a placebo cream once daily for four weeks. Researchers measured how well it cleared skin and reduced itching compared to the placebo.

This was an early safety study of a new injectable drug called HDM1005, designed to help with weight management. It tested single doses in 65 healthy adults to check for side effects and see how the body processes the drug. Researchers also looked for early signs of its effect on…